Clinical trial / 1991
Weight reduction did not produce clinically meaningful shifts in serum lipoprotein(a) concentrations.
Fifty-two moderately obese white adults participated in a 104-week placebo-controlled, double-blind weight reduction intervention combining lifestyle modifications with fenfluramine and phentermine. Baseline serum lipoprotein(a) displayed a skewed distribution comparable to that reported in healthy adults. Despite successful weight loss that normalized fasting insulin and standard lipid levels, no clinically significant modification in serum lipoprotein(a) occurred.
- Study type
- Double-blind, placebo-controlled trial
- Who was studied
- 52 moderately obese white adults (16 men, 36 women)
- What was measured
- Serum lipoprotein(a) and lipid profiles
THE PAPER
Effect of weight loss on serum lipoprotein(a) concentrations in an obese population.
Corsetti JP, Sterry JA, Sparks JD, Sparks CE, Weintraub M. Clin Chem, 1991.
This note is written from the study's published abstract. It summarizes what the authors reported; it is not medical advice and does not replace reading the full paper.